Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

2 Jan 2024 15:00

RNS Number : 3767Y
GSK PLC
02 January 2024

GSK plc

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 December 2023 consisted of 4,312,145,983 shares of 31 ΒΌ pence each ('Ordinary Shares'), of which 197,068,169 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,115,077,814. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notifications may be sent to company.secretary@gsk.com.

V A Whyte

Company Secretary

2 January 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRBBGDBSXGDGSD
Date   Source Headline
9th Apr 20197:00 amRNSFDA approves ViiV's two-drug HIV regimen, Dovato
2nd Apr 20191:00 pmRNSPublication of AGM and GM Shareholder Documents
1st Apr 20194:36 pmRNSTotal Voting Rights
28th Mar 20194:15 pmRNSGSK reporting changes - product sales and IFRS 16
25th Mar 20195:02 pmRNSDirector/PDMR Shareholding
21st Mar 20194:00 pmRNSGSK announces further positive data from DREAMM-1
19th Mar 20195:45 pmRNSData from GARNET study evaluating dostarlimab
18th Mar 20197:00 amRNSGSK Annual Report 2018 on Form 20-F
12th Mar 20193:19 pmRNSDirector/PDMR Shareholding
12th Mar 20191:00 pmRNSAnnual Financial Report
11th Mar 20196:24 pmRNSDirector/PDMR Shareholding
8th Mar 20197:00 amRNSViiV positive ph3 data for long acting injectable
5th Mar 20195:20 pmRNSDirector/PDMR Shareholding
1st Mar 201910:10 amRNSTotal Voting Rights
22nd Feb 20195:30 pmRNSDirector/PDMR Shareholding
22nd Feb 201911:21 amRNSGSK response to SFO Statement
21st Feb 20194:37 pmRNSDirector/PDMR Shareholding
21st Feb 20194:15 pmRNSDirector/PDMR Shareholding
20th Feb 20192:44 pmRNSDirector/PDMR Shareholding
19th Feb 20192:26 pmRNSDirector/PDMR Shareholding
19th Feb 20191:53 pmRNSDirector/PDMR Shareholding Replacement
19th Feb 20191:41 pmRNSDirector/PDMR Shareholding
18th Feb 20195:13 pmRNSDirector/PDMR Shareholding
18th Feb 20194:14 pmRNSDirector/PDMR Shareholding
15th Feb 20196:19 pmRNSDirector/PDMR Shareholding
15th Feb 20196:16 pmRNSDirector/PDMR Shareholding
15th Feb 20195:39 pmRNSDirector/PDMR Shareholding
14th Feb 201910:33 amRNSDirector/PDMR Shareholding
12th Feb 20192:05 pmRNSDirector/PDMR Shareholding
12th Feb 20192:03 pmRNSDirector/PDMR Shareholding
11th Feb 201912:42 pmRNSDirector/PDMR Shareholding
11th Feb 201912:40 pmRNSDirector/PDMR Shareholding
11th Feb 201912:38 pmRNSDirector/PDMR Shareholding
11th Feb 201912:02 pmRNSDirector/PDMR Shareholding
11th Feb 201912:01 pmRNSDirector/PDMR Shareholding
8th Feb 201912:17 pmRNSDirector/PDMR Shareholding
8th Feb 201912:16 pmRNSDirector/PDMR Shareholding
6th Feb 201912:20 pmRNSDirector/PDMR Shareholding
6th Feb 201912:01 pmRNSFinal Results
5th Feb 201911:58 amRNSGSK and Merck announce global alliance for M7824
1st Feb 20193:45 pmRNSTotal Voting Rights
23rd Jan 20191:10 pmRNSDirector/PDMR Shareholding
22nd Jan 20191:56 pmRNSGSK completes acquisition of TESARO
21st Jan 20197:00 amRNSGSK Chairman succession process
15th Jan 20195:15 pmRNSDirector/PDMR Shareholding
15th Jan 20194:09 pmRNSDirector/PDMR Shareholding
15th Jan 20193:01 pmRNSDirector/PDMR Shareholding
15th Jan 20192:59 pmRNSDirector/PDMR Shareholding
15th Jan 20192:56 pmRNSDirector/PDMR Shareholding
15th Jan 20192:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.